PEDIATRIC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pediatric, and what generic alternatives are available?
Pediatric is a drug marketed by Haleon Us Holdings, Abbott, and Hospira. and is included in three NDAs.
The generic ingredient in PEDIATRIC is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pediatric
A generic version of PEDIATRIC was approved as lidocaine hydrochloride by PHARMOBEDIENT on November 18th, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PEDIATRIC?
- What are the global sales for PEDIATRIC?
- What is Average Wholesale Price for PEDIATRIC?
Summary for PEDIATRIC
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| DailyMed Link: | PEDIATRIC at DailyMed |
US Patents and Regulatory Information for PEDIATRIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | PEDIATRIC ADVIL | ibuprofen | SUSPENSION/DROPS;ORAL | 020812-001 | Jan 30, 1998 | DISCN | Yes | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Abbott | PEDIATRIC LTA KIT | lidocaine hydrochloride | SOLUTION;TOPICAL | 088572-001 | Jul 31, 1984 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| Hospira | PEDIATRIC LTA KIT | lidocaine hydrochloride | SOLUTION;TOPICAL | 085995-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
